Spyglass Capital Management LLC bought a new position in shares of Astera Labs, Inc. (NASDAQ:ALAB – Free Report) during the third quarter, HoldingsChannel.com reports. The firm bought 736,121 shares of the company’s stock, valued at approximately $38,565,000. Astera Labs makes up approximately 2.5% of Spyglass Capital Management LLC’s holdings, making the stock its 22nd largest holding.
Other large investors also recently modified their holdings of the company. Avior Wealth Management LLC purchased a new stake in shares of Astera Labs in the 3rd quarter valued at approximately $361,000. Meeder Asset Management Inc. purchased a new stake in shares of Astera Labs in the 3rd quarter valued at approximately $1,141,000. Bank of Hawaii purchased a new stake in shares of Astera Labs in the 3rd quarter valued at approximately $1,409,000. Vanguard Group Inc. purchased a new stake in shares of Astera Labs in the 1st quarter valued at approximately $127,268,000. Finally, Rakuten Securities Inc. purchased a new stake in shares of Astera Labs in the 3rd quarter valued at approximately $291,000.
Astera Labs Trading Down 5.6 %
Shares of NASDAQ:ALAB opened at $99.60 on Friday. Astera Labs, Inc. has a 1-year low of $36.22 and a 1-year high of $113.85. The firm has a fifty day moving average price of $74.17 and a 200 day moving average price of $60.84.
Insider Transactions at Astera Labs
In related news, insider Sanjay Gajendra sold 76,701 shares of the firm’s stock in a transaction dated Tuesday, September 17th. The shares were sold at an average price of $45.32, for a total value of $3,476,089.32. Following the completion of the sale, the insider now owns 855,000 shares in the company, valued at $38,748,600. This trade represents a 8.23 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CEO Jitendra Mohan sold 173,366 shares of the firm’s stock in a transaction dated Monday, November 25th. The shares were sold at an average price of $110.12, for a total transaction of $19,091,063.92. Following the completion of the sale, the chief executive officer now owns 600,000 shares of the company’s stock, valued at $66,072,000. This trade represents a 22.42 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 1,897,820 shares of company stock worth $168,252,298.
Wall Street Analysts Forecast Growth
A number of research analysts recently commented on ALAB shares. Deutsche Bank Aktiengesellschaft increased their target price on shares of Astera Labs from $60.00 to $100.00 and gave the company a “buy” rating in a research report on Tuesday, November 5th. Craig Hallum increased their target price on shares of Astera Labs from $75.00 to $105.00 and gave the company a “buy” rating in a research report on Tuesday, November 5th. JPMorgan Chase & Co. increased their target price on shares of Astera Labs from $70.00 to $110.00 and gave the company an “overweight” rating in a research report on Tuesday, November 5th. Stifel Nicolaus increased their target price on shares of Astera Labs from $80.00 to $100.00 and gave the company a “buy” rating in a research report on Tuesday, November 5th. Finally, Morgan Stanley increased their target price on shares of Astera Labs from $74.00 to $94.00 and gave the company an “overweight” rating in a research report on Tuesday, November 5th. Twelve analysts have rated the stock with a buy rating, Based on data from MarketBeat, the stock currently has a consensus rating of “Buy” and a consensus price target of $94.67.
Read Our Latest Analysis on Astera Labs
Astera Labs Profile
Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.
Further Reading
- Five stocks we like better than Astera Labs
- Stock Analyst Ratings and Canadian Analyst Ratings
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- What is a buyback in stocks? A comprehensive guide for investors
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- What is a support level?
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALAB – Free Report).
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.